~~<i id='CDD3A64C36'><strike id='CDD3A64C36'><tt id='CDD3A64C36'><pre id='CDD3A64C36'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

entertainment

author：focus 2025-10-01 01:00:05 - browse：468

A new Ebola epidemic in the Democratic Republic of the Congo is shaping up to be the most dangerous and difficult test of the world’s ability to contain the disease since the catastrophic West African outbreak in 2014 and 2015. What challenges are responders facing? And how might experimental vaccines be used to try to slow the spread of the epidemic?

See below for an archived chat with Helen Branswell about these issues and more.

Previous article： DIEP, the 'gold standard' of breast reconstruction, is under threat
Next article： He's 19 months old and has one of the world’s rarest diseases

explore

entertainment

explore

knowledge

focus

AmastcellAdobeEachyear,morethan400millionurinarytractinfectionsoccurinpeoplearoundtheglobe.Andresear

WSS

Immune cells and nerve overgrowth may explain recurring UTI pain

$1 billion proposal to grow Boston, Massachusetts biotech

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

Families look for replacement for GSK asthma drug Flovent

He's 19 months old and has one of the world’s rarest diseases

Medical records are filled with copy

entertainment

entertainment

explore

The high cost of giving birth even with insurance

How to save PrEP access — and even expand it

Anesthesiologist group: stop taking Ozempic before surgery

Longer MASH drug regimen improved liver, Akero study finds

Sports medicine is finally prioritizing gender equality

Bright Health sells Medicare Advantage business to Molina

Supreme Court strikes down use of affirmative action

Cancer drug shortages should be causing more outrage

United colonoscopy coverage change 'may cost lives,' doctors say

Medicare drug price negotiation hearing pits pharma v Biden admin

entertainment

For AI in health care standards, federal regulators join with industry group

Families look for replacement for GSK asthma drug Flovent

The public health thinking behind the CDC’s new Covid guidance

Tori Bowie and the unacceptable rates of Black maternal death

Duchenne breakthrough therapy leaves behind pioneering families

Readout Newsletter: BridgeBio, Akero, and human embryo models

explore

explore

knowledge

focus